ArticleJournal of translational internal medicine2024

Successful management of a high-risk acute myeloid leukemia patient with severe coronary heart disease by venetoclax plus azacytidine and coronary artery bypass grafting.

Wen-Jing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.